No earnings within 2 weeks of this transaction.
| Insider | Feld Michael |
|---|---|
| Title | EVP, CRO & Pres. Life Sciences |
| Transaction Date | Dec 26, 2025 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Dec 29, 2025 |
| Document Date | Dec 26, 2025 |
| Shares Sold | 74 |
| Price per Share | $196.08 |
| Total Value | $14,509.92 |
| Shares Owned After | 16,506 |
| Derivative | No |
| Accession Number | 0001628280-25-058843 |
| Document | View SEC Filing |